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Abstract: Pseudomonas aeruginosa is one of the leading nosocomial pathogens in intensive care units (ICU). This oppor-
tunist pathogen is commonly recovered from moist environments, and is also found colonizing 2.6 to 24% of hospitalized 
patients. We reviewed the recent literature that used highly discriminatory typing methods to precisely identify the reser-
voirs and modes of transmission of this microorganism in the ICU setting. In most ICUs, the endogenous flora was sus-
pected to be the main source of infection compared to exogenous sources (other patients, the contaminated environment 
such as sinks or taps). However, the percentage of endogenous versus exogenous sources might vary considerably from 
one setting to another. Reasons for this include the compliance of health care workers to infection control measures, the 
contamination of the environment, and probably also the biology of the pathogen (intrinsic fitness factors). As P. aerugi-
nosa is ubiquitous in the environment and colonizes up to 15% of hospitalized patients, eradication of the reservoir is dif-
ficult, if not impossible. Therefore, efforts should primarily focus on reinforcement of infection control measures to limit 
its transmission. 
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INTRODUCTION 
 Pseudomonas aeruginosa is an ubiquitous environmental 
bacterium with minimal requirements for survival and a re-
markable ability to adapt to a variety of environmental chal-
lenges. However, nearly all cases of infection occur in hosts 
with compromised immune defense. Nosocomial infections 
are known to affect most often neutropenic patients and oth-
erwise immuno-compromized patients in intensive care units 
(ICUs). Given the widespread presence of P. aeruginosa in 
the environment, it is noteworthy that diseases attributable to 
it are quite rare in otherwise healthy individuals. Indeed, 
each day we contact P. aeruginosa by millions in our food, 
by thousands on the implements used to bathe us, and some-
times even in the drinking water in low numbers [1]. 
 Although humans contact large numbers of P. aerugi-
nosa, the species only colonize the normal human host in-
termittently. In contrast, it was found to be part of the intes-
tinal flora of 2.6 to 24% of hospitalized patients [2]. How-
ever, the concentration was low (<10
2-3
 /g) and at a signifi-
cant competitive disadvantage to the major endogenous 
normal flora, which achieves concentration of at least 10
8
/g. 
Nevertheless, the importance of P. aeruginosa as an oppor-
tunistic pathogen relies in its ability to activate useful pheno-
types under environmental stress and to persist in adverse 
conditions such as the presence of antibiotic or antiseptic 
substances. The production of a slime layer provides a sig-
nificant adaptation to a wide variety of adverse environ-
mental conditions. 
 P. aeruginosa does not attack normal tissues. Intact skin 
and  mucous membranes  therefore provide  an initial  barrier  
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against the attachment of the bacteria. Specific conditions 
must be met for the establishment of infection: the bacteria 
must contact the target organ in large numbers and possess 
certain virulence factors; the host must possess certain de-
fects in its defense and immune system; and particular mi-
croenvironmental signals must be generated to activate the 
bacterium (quorum sensing) [3]. 
 Beside patients with cystic fibrosis for whom P. aerugi-
nosa was the main death threat for several decades, risk fac-
tors for an infection with P. aeruginosa in the hospitalized 
patients include mechanical ventilation, chronic obstructive 
pulmonary disease, burned wounds and previous antibiotic 
therapy. New categories of patients susceptible to this patho-
gen have appeared and the number of patients in these cate-
gories is constantly increasing as new medical therapies 
against cancer are developed and applied and the transplanta-
tion of solid organs, skin, and bone marrow is made possible. 
Modern medical technology has created new specific niches 
for opportunist pathogens. 
 An infection with P. aeruginosa in the hospital manifests 
primarily as acute lung infection in ICU patients. In the 
European Prevalence of Infection in Intensive Care Study, 
up to 28% of nosocomial infections were attributed to P. 
aeruginosa [4]. In the first study on the prevalence of noso-
comial infections in Swiss university hospitals, P. aerugi-
nosa was the third agent responsible for infection (11%) fol-
lowing the infective agents Staphylococcus aureus and Es-
cherichia coli [5]. 
Source of P. aeruginosa Infection: Lesson from Molecu-
lar Epidemiology 
 As P. aeruginosa is ubiquitous in the environment and is 
also part of the endogenous flora of hospitalized patients, 
only studies using powerful molecular typing methods can 
explore the routes of colonization and/or infection. We ad-
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dressed elsewhere the caution required for application of 
these methods [6]. 
 The question we would like to raise here is whether P. 
aeruginosa infections in ICU patients are mainly due to en-
dogenous or exogenous sources. In addition, when the source 
is exogenous, we would like also to know the respective role 
of patient-to-patient and environment-to-patient transmis-
sion. A better understanding of the epidemiology of P. aeru-
ginosa in the ICU setting would allow improvement in infec-
tion control measures. 
Evidence in Favour of Endogenous Infection 
 Several recent studies using molecular typing in a non-
epidemic ICU setting suggested that the major reservoir of P. 
aeruginosa was the endogenous flora of the patient. These 
observation raised doubt on the value of barrier precautions 
for prevention of P. aeruginosa colonization or infection. In 
one of the first studies that investigated this topic, a German 
team prospectively searched for P. aeruginosa in patients, 
staff members and environment during a 4-month period in a 
surgical ICU [7,8]. They found a low number of patients 
with P. aeruginosa (18/153, 12%), most of which were colo-
nized by a unique genotype, suggesting endogenous coloni-
zation (only 2 possible transmissions from patient to patient 
were suspected). 
 Berthelot et al. investigated the respective contribution of 
endogenous and exogenous transmission of P. aeruginosa in 
mechanically ventilated patients [9]. The presence of P. 
aeruginosa was prospectively examined in the respective 
patients and in the environment. The origin of lung coloniza-
tion was endogenous in 80% of the cases (21/26). 
 In a Dutch ICU, Bonten et al. prospectively investigated 
the patient’s colonization and infection with P. aeruginosa 
during a period of endemicity [10]. They found that the res-
piratory tract colonization was of exogenous origin in only 
8% of the cases. 
 In a similar study, Speijer et al. concluded that the small 
number of identified patient-to-patient transmissions (5 
among 49 patients with P. aeruginosa) and the large number 
of genotypes found indicated that most P. aeruginosa strains 
originated from the patients themselves [11]. 
Evidence in Favour of Exogenous Infection 
 On the other hand, other studies have shown that trans-
missions from patient to patient or from environment to pa-
tient played an important role. Cross-colonization was high-
lighted in a study by Bergmans et al. [12]. They prospec-
tively investigated the colonization and/or infection of 100 
patients in two ICUs during a period of endemicity. In 16 of 
23 patients with P. aeruginosa, a nosocomial acquisition was 
suspected. In another study, Thuong et al. conducted a pro-
spective epidemiological investigation because of a high 
prevalence of P. aeruginosa infections in their ICU patients 
[13]. They found that 67% of the patients harbored an identi-
cal P. aeruginosa genotype, suggestive of the dissemination 
of an epidemic strain. Cross-colonization occurred fre-
quently, but the role of the environment was not evaluated 
during this investigation. Similarly, in a 6-mounth prospec-
tive study, cross-transmission was suspected in 46% of the 
patients [22]. However, as no environmental or staff sam-
pling was performed, the source of contamination could not 
be assessed. 
 The potable water was also associated with P. aeruginosa 
infection [14], especially when it was used for hydrotherapy 
of burn patients [15,16] or rinsing medical devices after dis-
infections [17]. In burn patients, Tredget et al. showed that 
hydrotherapy was a significant risk for P. aeruginosa infec-
tions [16]. 
 The environment was suspected to be a non-negligible 
source when the aerator faucets and the sinks were highly 
contaminated with P. aeruginosa [18,19]. A recent prospec-
tive investigation over a 40-week period showed that tap 
water from faucets contaminated with P. aeruginosa played 
a crucial role (42% of patients infected with P. aeruginosa in 
clinical specimens) in the propagation of this pathogen not 
only to ICU patients, but also to patients from other adjacent 
wards, through patient-to-patient transmissions [20]. This 
investigation also showed that taps could be contaminated 
with the same P. aeruginosa genotype over an extended pe-
riod of time (up to 2 years). A similar investigation was per-
formed on intubated patients in a Spanish hospital during a 
3-year prospective study [21]. The authors found that the 
source of strains causing ICU-acquired colonization was 
predominantly environmental, in most cases responsible was 
the tap water in the patient's room. 
 It has been suggested that P. aeruginosa can readily con-
taminate staff hands, presumably by water splashed from 
sinks during hand washing. However, Grundman et al. failed 
to experimentally contaminate hands when sterile water was 
splashed directly into densely colonized sinks [23]. The 
authors proposed a direct transmission from the tap water to 
the patient (in their case by bathing neonates). 
 We have also investigated the hypothetical role of tap 
colonization with P. aeruginosa in ICU patients of our hos-
pital [24,25], despite the fact that relatively few faucets of 
the units (12%) were colonized. A prospective molecular 
epidemiological investigation was performed during a non-
epidemic period with a duration of one year (1998). The in-
cidence of patients with clinical specimens positive for P. 
aeruginosa was 55.7 infected patients (cases)/1000 admitted 
patients (admissions). We found that 42% of the cases (23.6 
cases/1000 admissions) had isolates identical to those found 
in the taps. Although the initial contamination of the taps 
could originate from retrograde colonization, most of the P. 
aeruginosa genotypes (82%) were recovered from the taps 
before they were isolated from patients. This finding 
strongly suggests that the water system was the primary res-
ervoir. Among patients with isolates that were not found in 
the taps, 30% (16.5 cases/1000 admissions) had isolates 
identical to those of at least one other patient hospitalized 
during the same period in the same unit, suggesting a possi-
ble patient-to-patient transmission. In the remaining 28% of 
the cases (15.6 cases/1000 admissions), the isolates showed a 
unique typing pattern, indicating that the source was proba-
bly endogenous. Control measures were taken in order to 
reduce i) the presence of P. aeruginosa in taps, ii) the use of 
tap water for certain patient care procedures (replacement of 
tap water by P. aeruginosa-free bottled water for drinking 
and mouth wash of patients), and iii) the transmission from 
patient to patient. In 2000, the same molecular epidemiologi-
cal investigation was done [26]. Despite the fact that the 
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same proportion of taps contaminated with P. aeruginosa 
was observed, the incidence of patients with P. aeruginosa 
from exogenous source (identical to isolates from the taps or 
to another patient) decreased by a factor of 3 (13.5 
cases/1000 admissions in 2000 versus 40.1 cases/1000 ad-
missions in 1998), whereas the incidence of patients with 
isolates showing a unique pattern remained the same (13.1 
cases/1000 admissions in 2000 versus 15.6 in 1998). As the 
decrease of cases was similarly observed in both patients 
with isolates from the taps and patients with isolates identi-
cal to other patients, and as the eradication of P. aeruginosa 
in the taps did fail, the main effect of the infection control 
measures relies probably on the transmission of the patho-
gen. The principal measures that were responsible for this 
effect might be the introduction of an alcoholic solution for 
hand disinfections and the reinforcement of standard precau-
tions. Similar results were obtained by Trautmann et al. who 
showed that during a one-year period of time, 50% of pa-
tients infected or colonized with P. aeruginosa shared a 
similar genotype that the one found in tap water [27]. 
 Although most P. aeruginosa infections are endemic, 
outbreaks have also been described and contribute to the 
extent of infections of exogenous origin. Recent reports of P. 
aeruginosa outbreaks were due to multidrug-resistant geno-
types, which complicate the treatment of infections. Bert et 
al. reported an outbreak of multi-resistant P. aeruginosa in-
volving 36 patients in a neurosurgery ICU [28]. The strain 
was cultured from enteral nutrition solutions as well as from 
tap water and sinks. Control of the outbreak was possible 
after reinforcement of isolation procedures for infected pa-
tients, modification in the mode of enteral nutrition and re-
placement of all sinks in the unit. Concern about multidrug-
resistant strains was also highlighted in the report by Hsueh 
et al. who traced the spread of a single strain of P. aerugi-
nosa over a period of several years [29]. Berthelot et al. also 
reported the occurrence of one multi-resistant genotype in 
patients and in sinks during their prospective investigation of 
P. aeruginosa in ICU patients (9). The situation resolved 
when chlorine disinfection of sinks was reinforced. 
CONCLUSIONS 
 Review of all these molecular investigations on the epi-
demiology of P. aeruginosa in the ICU setting shows that 
the contribution of endogenous versus exogenous reservoirs 
to the colonization and infection of patients varies according 
to the compliance of health care workers to infection control 
measures, to the contamination of the environment, and 
probably also to the biology of the pathogen (intrinsic fac-
tors) (Fig. 1). Nevertheless, as the environment was found to 
play an important role in several investigations, the question 
is, should we eradicate this reservoir, and how? Taps con-
taminated with P. aeruginosa were shown to serve as a con-
tinuous source for transmission [20,27], but, it appears al-
most impossible to eradicate this contamination. One possi-
ble option might be the use of microfiltres at each tap (end 
line filtration) [30,31]. Regular disinfection of contaminated 
sinks was shown to reduce the number of nosocomial infec-
tions due to P. aeruginosa [32] and was able to eradicate 
multi-resistant strains [9]. On the other hand, in our investi-
gation [25], control measures against the transmission of the 
pathogen, e.g. alcoholic solution for hand disinfection, were 
probably responsible for the decrease of P. aeruginosa infec-
tions in ICU patients. 
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Fig. (1). Schematic representation of the factors contributing to the epidemiology of Pseudomonas aeruginosa in the Intensive Care Units. 
Other patients or contaminated environment are potential exogenous sources of infections. Failure in a disinfection procedure, the use of 
contaminated product or device are often cited as the source of epidemics. Intrinsic factors of the bacteria (e.g. multidrug-resistance) might 
also play a role in epidemics. On the other hand, colonization of the gastro-intestinal track, the trachea or the skin are the major endogenous 
sources of infections. Infections in the patients will occurred only if an opportunity is given to the pathogen (e.g. antibiotic therapy, immuno-
supression, port of entry). 
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 As P. aeruginosa is ubiquitous in the environment and 
colonizes up to 15% of hospitalized patients, eradication of 
the reservoir is difficult, if not impossible. Therefore, efforts 
should primarily focus on the reinforcement of infection con-
trol measures to limit the transmission of P. aeruginosa. 
However, when a multi-resistant strain is repetitively recov-
ered from patients and from the environment, efforts should 
be undertaken to achieve eradication of this strain from the 
environment. 
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